GB0712626D0 - Medicament for the treatment of endometriosis - Google Patents

Medicament for the treatment of endometriosis

Info

Publication number
GB0712626D0
GB0712626D0 GBGB0712626.1A GB0712626A GB0712626D0 GB 0712626 D0 GB0712626 D0 GB 0712626D0 GB 0712626 A GB0712626 A GB 0712626A GB 0712626 D0 GB0712626 D0 GB 0712626D0
Authority
GB
United Kingdom
Prior art keywords
endometriosis
medicament
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0712626.1A
Other versions
GB2450533A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring International Center SA
Original Assignee
Ferring International Center SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring International Center SA filed Critical Ferring International Center SA
Priority to GB0712626A priority Critical patent/GB2450533A/en
Publication of GB0712626D0 publication Critical patent/GB0712626D0/en
Priority to SA08290041A priority patent/SA08290041B1/en
Priority to AT08751001T priority patent/ATE516805T1/en
Priority to MX2009008191A priority patent/MX2009008191A/en
Priority to PL08751001T priority patent/PL2109449T3/en
Priority to SI200830385T priority patent/SI2109449T1/en
Priority to TW097103971A priority patent/TWI411436B/en
Priority to ARP080100431A priority patent/AR065139A1/en
Priority to NZ578569A priority patent/NZ578569A/en
Priority to EP08751001A priority patent/EP2109449B1/en
Priority to JP2009547780A priority patent/JP5211073B2/en
Priority to RU2009129252/15A priority patent/RU2423146C2/en
Priority to AU2008211633A priority patent/AU2008211633B2/en
Priority to PCT/IB2008/001273 priority patent/WO2008093247A2/en
Priority to DK08751001.2T priority patent/DK2109449T3/en
Priority to BRPI0806944-1A2A priority patent/BRPI0806944A2/en
Priority to ES08751001T priority patent/ES2370091T3/en
Priority to US12/525,342 priority patent/US8927568B2/en
Priority to PT08751001T priority patent/PT2109449E/en
Priority to CN2008800038285A priority patent/CN101641098B/en
Priority to CA2676910A priority patent/CA2676910C/en
Priority to JO200833A priority patent/JO2730B1/en
Publication of GB2450533A publication Critical patent/GB2450533A/en
Priority to IL200032A priority patent/IL200032A/en
Priority to HK10103367.7A priority patent/HK1134911A1/en
Priority to US14/543,478 priority patent/US9023862B2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0712626A 2007-02-01 2007-06-29 Treatment and prevention of endometriosis using dopamine agonists. Withdrawn GB2450533A (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GB0712626A GB2450533A (en) 2007-06-29 2007-06-29 Treatment and prevention of endometriosis using dopamine agonists.
SA08290041A SA08290041B1 (en) 2007-02-01 2008-01-30 Medicament for the Treatment of Endometriosis
CA2676910A CA2676910C (en) 2007-02-01 2008-02-01 Medicament for the treatment of endometriosis
AU2008211633A AU2008211633B2 (en) 2007-02-01 2008-02-01 Medicament for the treatment of endometriosis
BRPI0806944-1A2A BRPI0806944A2 (en) 2007-02-01 2008-02-01 ENDOMETRIOSIS TREATMENT MEDICINE
PL08751001T PL2109449T3 (en) 2007-02-01 2008-02-01 Medicament for the treatment of endometriosis
SI200830385T SI2109449T1 (en) 2007-02-01 2008-02-01 Medicament for the treatment of endometriosis
TW097103971A TWI411436B (en) 2007-02-01 2008-02-01 Medicament for the treatment of endometriosis
ARP080100431A AR065139A1 (en) 2007-02-01 2008-02-01 MEDICATION FOR THE TREATMENT OF ENDOMETRIOSIS
NZ578569A NZ578569A (en) 2007-02-01 2008-02-01 Medicament for the treatment of endometriosis using dopamine agonists cabergoline or quinagolide
EP08751001A EP2109449B1 (en) 2007-02-01 2008-02-01 Medicament for the treatment of endometriosis
JP2009547780A JP5211073B2 (en) 2007-02-01 2008-02-01 Drugs for the treatment of endometriosis
RU2009129252/15A RU2423146C2 (en) 2007-02-01 2008-02-01 Medication for treating endometriosis
AT08751001T ATE516805T1 (en) 2007-02-01 2008-02-01 MEDICINE FOR TREATING ENDOMETRIOSIS
PCT/IB2008/001273 WO2008093247A2 (en) 2007-02-01 2008-02-01 Medicament for the treatment of endometriosis
DK08751001.2T DK2109449T3 (en) 2007-02-01 2008-02-01 Drug for the treatment of endometriosis
MX2009008191A MX2009008191A (en) 2007-02-01 2008-02-01 Medicament for the treatment of endometriosis.
ES08751001T ES2370091T3 (en) 2007-02-01 2008-02-01 MEDICATION FOR THE TREATMENT OF ENDOMETRIOSIS.
US12/525,342 US8927568B2 (en) 2007-02-01 2008-02-01 Medicament for the treatment of endometriosis
PT08751001T PT2109449E (en) 2007-02-01 2008-02-01 Medicament for the treatment of endometriosis
CN2008800038285A CN101641098B (en) 2007-02-01 2008-02-01 medicament for the treatment of endometriosis
JO200833A JO2730B1 (en) 2007-02-01 2008-02-02 Medicament for the treatment of endometriosis
IL200032A IL200032A (en) 2007-02-01 2009-07-23 Dopamine agonist for use in the treatment or prevention of endometriosis
HK10103367.7A HK1134911A1 (en) 2007-02-01 2010-04-01 Medicament for the treatment of endometriosis
US14/543,478 US9023862B2 (en) 2007-02-01 2014-11-17 Medicament for the treatment of endometriosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0712626A GB2450533A (en) 2007-06-29 2007-06-29 Treatment and prevention of endometriosis using dopamine agonists.

Publications (2)

Publication Number Publication Date
GB0712626D0 true GB0712626D0 (en) 2007-08-08
GB2450533A GB2450533A (en) 2008-12-31

Family

ID=38420926

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0712626A Withdrawn GB2450533A (en) 2007-02-01 2007-06-29 Treatment and prevention of endometriosis using dopamine agonists.

Country Status (2)

Country Link
ES (1) ES2370091T3 (en)
GB (1) GB2450533A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0208417A3 (en) * 1985-06-12 1989-09-06 SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu Use of 1-(8-alpha-ergolinyl)-3,3-diethyl urea derivatives in the treatment of endometritis
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
RU2273481C2 (en) * 2004-05-27 2006-04-10 Варвара Анатольевна Волкова Method for enhancing effectiveness of infertility treatment caused by small-scale external genital endometriosis

Also Published As

Publication number Publication date
GB2450533A (en) 2008-12-31
ES2370091T3 (en) 2011-12-12

Similar Documents

Publication Publication Date Title
HUS1800011I1 (en) Combination therapy of substituted oxazolidinones
HK1224200A1 (en) Medicament for the treatment of cancer of the pancreas
GB0602178D0 (en) Therapeutic treatment
SI2054088T1 (en) Device for the treatment of containers
GB0921075D0 (en) Novel combination of the therapeutic agents
ZA201001264B (en) 1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus
GB0608655D0 (en) Therapeutic Treatment
IL205137A0 (en) 5-cyanothienopyridines for the treatment of tumours
GB0906159D0 (en) Drug combination for the treatment of proteostatic diseases
HK1134911A1 (en) Medicament for the treatment of endometriosis
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
ZA201007362B (en) Conjugates for the treatment of mesothelioma
GB0610909D0 (en) Therapeutic treatment
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
GB0723100D0 (en) Treatment of HFnEF
EP2023894A4 (en) Fixed combination dosage forms for the treatment of migraine
ZA200905300B (en) Medicament for the treatment of endometriosis
HK1139050A1 (en) Medicament for the treatment of pneumonia
GB0717450D0 (en) Medicament
GB0712626D0 (en) Medicament for the treatment of endometriosis
IL215854A0 (en) Pharmaceutical compositions for the treatment of nasal polyposis
GB0602857D0 (en) The treatment of sialorrhoea
GB0610376D0 (en) Therapeutic treatment
GB0809319D0 (en) The treatment of puritus
GB0602858D0 (en) The treatment of sialorrhoea

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)